SCHEMBL6690931

SCHEMBL6690931

CN1CCN(S(=O)(=O)c2ccc3c(c2)[nH]c(=O)c2cc(F)ccc23)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.64
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
TDP1 Q9NUW8 1/20 0.49
KDR P35968 1/20 0.47
KDM4E B2RXH2 2/20 0.47
HTR6 P50406 1/20 0.47
HSD17B10 Q99714 4/20 0.46
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
PKM P14618 1/20 0.45
POLB P06746 1/20 0.45
BLM P54132 1/20 0.45
VCAM1 P19320 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5356996 0.75 KDR (0.79) MEN1KMT2ATDP1KDRKDM4E
SCHEMBL5362476 0.74 KDR (0.65) MEN1KMT2ATDP1KDRKDM4E
SCHEMBL424172 0.73 PKM (0.71) MEN1KMT2ATSHRSMN1; SMN2HPGD
SCHEMBL6690145 0.70 PARP1 (0.65) PARP1KMT2ACYP2C19PKMPOLB
SCHEMBL27345125 0.70 ATM (0.63) MEN1KMT2AKDM4ETSHRSMN1; SMN2
SCHEMBL6035014 0.69 ATM (0.54) KDM4ETSHRSMN1; SMN2PKMPOLB
SCHEMBL31347322 0.69 ATM (0.54) KDM4ETSHRSMN1; SMN2PKMPOLB
SCHEMBL25941353 0.69 ALDH1A1 (0.65) KDM4EHTR6TSHRMAPTPKM
SCHEMBL5355475 0.68 KDR (0.68) MEN1KMT2ATDP1KDRKDM4E
SCHEMBL14590416 0.67 KDR (0.88) MEN1KMT2AKDRKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6723733-B2 POLYMERASE INHIBITOR GUILFORD PHARMACEUTICALS, INC. 2004-04-20 US disclosed
US-20020006927-A1 Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses EISAI INC. 2002-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020006927-A1 Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses PARP1, PARP2, PARP6 PARP1 1/4885MEN1 2882/4885KMT2A 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.